V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250007691 | 250005355 | 1.74 | null | Palliative (P) | 2016-09-27 | 2016-09-27 | CARBOPLATIN + ETOPOSIDE | N | N | 250032697 | CARBOPLATIN + ETOPOSIDE |
| 250007692 | 250005356 | 1.78 | 87.8 | Neo-adjuvant (N) | 2013-10-06 | 2013-10-06 | DA 3 + 10 | 2 | N | 250032698 | VINORELBINE |
| 250007693 | 250005357 | 1.53 | 75.2 | Disease modification (D) | 2014-06-09 | 2014-06-15 | IPM | 02 | N | 250032699 | ENZALUTAMIDE |
| 250007694 | 250005358 | 1.6 | 88.6 | Disease modification (D) | 2014-11-21 | 2014-11-22 | MESO-02 TRIAL | N | N | 250032705 | AZACITIDINE |
| 250007695 | 250005358 | null | null | Adjuvant (A) | 2014-06-01 | 2014-06-11 | FLAG + Idarubicin | 02 | N | 250032705 | CYTARABINE |
| 250007696 | 250005358 | 1.73 | null | Palliative (P) | 2017-05-17 | 2017-05-17 | Enzalutamide | 02 | N | 250032705 | CYTARABINE |
| 250007697 | 250005358 | null | null | Palliative (P) | 2014-05-05 | 2017-01-15 | Chlorambucil | N | N | 250032705 | TRIAL |
| 250007698 | 250012714 | 1.74 | null | Disease modification (D) | 2015-04-08 | 2015-04-08 | Azacitidine | Y | N | 250032724 | TRIAL |
| 250007699 | 250005359 | null | null | Curative (C) | 2018-01-24 | 2018-01-24 | ABVD | N | N | 250032729 | TRIAL |
| 250007700 | 250005360 | 1.87 | 88 | Palliative (P) | 2014-11-02 | 2014-11-02 | Rituximab | N | N | 250032732 | VINORELBINE |
| 250007701 | 250005360 | 1.59 | null | Adjuvant (A) | 2014-10-27 | 2014-10-30 | Carboplatin + Vinorelbine IV | 2 | N | 250032732 | TRIAL |
| 250007702 | 250005360 | 1.4 | 78.9 | Adjuvant (A) | 2013-06-17 | 2013-06-17 | Docetaxel 75mg/m2 (21 day) | N | N | 250032732 | VINORELBINE |
| 250007703 | 250005360 | 1.67 | 61.9 | Palliative (P) | 2015-09-17 | 2015-09-20 | Pemetrexed | 01 | N | 250032732 | RUXOLITINIB |
| 250007704 | 250005360 | 1.65 | 80.8 | Neo-adjuvant (N) | 2014-11-10 | 2014-11-18 | Pemetrexed | N | N | 250032732 | TRIAL |
| 250007705 | 250012840 | 1.58 | 85 | Palliative (P) | 2015-08-11 | 2015-08-11 | Trial Unspecified | N | N | 250032754 | PEMETREXED |
| 250007706 | 250005361 | 1.58 | 88.3 | Disease modification (D) | 2017-04-16 | 2017-04-16 | Trial Unspecified | N | N | 250032755 | PEMETREXED |
| 250007707 | 250005362 | 1.77 | 0 | Disease modification (D) | 2018-02-14 | 2018-02-18 | Pazopanib | N | N | 250032756 | TRIAL |
| 250007708 | 250009807 | null | 62 | Palliative (P) | 2015-03-17 | 2015-03-17 | IPM | 02 | N | 250032758 | TRIAL |
| 250007709 | 250005363 | 1.64 | 71.6 | Neo-adjuvant (N) | 2014-10-21 | 2014-10-28 | Carboplatin + Etoposide IV 3 day | 02 | N | 250032761 | GEMCARBO |
| 250007710 | 250005363 | 0 | 0 | Curative (C) | 2017-04-17 | 2017-04-17 | MESO-02 TRIAL | N | N | 250032761 | ETOPOSIDE + LOMUSTINE + VINCRISTINE |
| 250007713 | 250005365 | 1.7 | null | Palliative (P) | 2016-01-10 | 2016-01-22 | Trial Unspecified | N | N | 250032775 | TRIAL |
| 250007714 | 250005365 | 1.78 | 73.8 | Palliative (P) | 2014-12-27 | 2014-12-27 | Bortezomib + Cyclophos + Dex | N | N | 250032775 | DOCETAXEL |
| 250007715 | 250005366 | 1.64 | 57.4 | Palliative (P) | 2013-04-03 | 2013-04-05 | Carboplatin 21day + Paclitaxel 7day | 2 | N | 250032777 | TRIAL |
| 250007716 | 250005367 | 0 | 70 | Palliative (P) | 2015-10-24 | 2015-10-24 | Trial Unspecified | 02 | N | 250032785 | TRIAL |
| 250007717 | 250009811 | null | 43.5 | Palliative (P) | 2015-07-16 | 2015-07-23 | Cisplatin | 2 | N | 250032787 | PEMETREXED |
| 250007718 | 250005368 | 1.73 | 61 | Curative (C) | 2016-06-19 | 2016-06-24 | GemCarbo Days 1+8 | N | N | 250032789 | MYELOMA XI TRIAL |
| 250007719 | 250009812 | 1.8 | null | Adjuvant (A) | 2014-05-14 | 2014-06-01 | IPM | Y | N | 250032791 | VINORELBINE |
| 250007720 | 250009812 | 1.71 | 63 | null | 2014-08-23 | 2014-08-26 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 2 | N | 250032791 | DOXORUBICIN + OLARATUMAB |
| 250007721 | 250009812 | null | 95.2 | Palliative (P) | 2015-03-11 | 2015-03-11 | Cytarabine low (10to20mg/m2) IV/SC | 02 | N | 250032791 | TRIAL |
| 250007722 | 250005369 | 1.5 | 0 | Disease modification (D) | 2013-11-22 | 2013-11-22 | BENDAMUSTINE + RITUXIMAB | 02 | N | 250032802 | EOX |
| 250007723 | 250005370 | 1.65 | 75.8 | Disease modification (D) | 2016-05-03 | 2016-05-03 | Bendamustine+Rituximab(Sub Courses) | 01 | N | 250032804 | CARBOPLATIN |
| 250007724 | 250009813 | 1.51 | 64.2 | Palliative (P) | 2014-10-28 | 2014-10-28 | DA 3 + 10 | 2 | N | 250032808 | CARBOPLATIN |
| 250007725 | 250009813 | 0 | 0 | Curative (C) | 2013-03-27 | 2013-03-27 | Trial Unspecified | N | N | 250032808 | IPM |
| 250007726 | 250009813 | 0 | 72 | Palliative (P) | 2017-02-23 | 2017-03-03 | Pemetrexed | N | N | 250032808 | GEMCITABINE |
| 250007727 | 250005371 | null | null | Palliative (P) | 2014-05-25 | 2014-05-26 | Cisplatin + Paclitaxel | 02 | N | 250032814 | NOT MATCHED |
| 250007728 | 250009814 | null | 66.2 | Disease modification (D) | null | 2016-09-29 | DOXORUBICIN | N | N | 250032815 | CARBOPLATIN |
| 250007729 | 250005372 | null | 101.8 | Palliative (P) | 2017-03-19 | 2017-03-19 | AML17 TRIAL | N | N | 250032817 | SCOT TRIAL |
| 250007730 | 250005372 | null | 66.2 | Palliative (P) | 2014-01-25 | 2014-01-26 | Trial Unspecified | 02 | N | 250032817 | TRIAL |
| 250007731 | 250005373 | null | null | Palliative (P) | 2014-05-21 | 2014-05-21 | Pemetrexed | null | N | 250032830 | PEMBROLIZUMAB |
| 250007732 | 250005373 | 0 | 0 | Disease modification (D) | 2015-03-31 | 2015-04-07 | Docetaxel 75mg/m2 (21 day) | N | N | 250032830 | PEMETREXED |
| 250007733 | 250011646 | 1.66 | 70.3 | Palliative (P) | 2013-04-18 | 2013-04-18 | MESO-02 TRIAL | null | N | 250032838 | CISPLATIN + PACLITAXEL |
| 250007734 | 250005374 | null | 0 | Palliative (P) | 2013-11-30 | 2013-12-09 | CHLVPP | 02 | N | 250032840 | CYTARABINE |
| 250007735 | 250005374 | 1.63 | null | Palliative (P) | 2017-12-23 | 2018-01-01 | Cisplatin | 2 | N | 250032840 | CARBOPLATIN + PACLITAXEL |
| 250007736 | 250005375 | 1.69 | null | Palliative (P) | 2018-04-10 | 2018-04-19 | Pemetrexed | N | null | 250032847 | DABRAFENIB |
| 250007737 | 250005375 | null | null | null | 2014-11-25 | 2014-11-27 | Cisplatin + Gemcitabine (D 1 & 8) | 01 | null | 250032847 | GEMCARBO |
| 250007739 | 250009819 | 1.62 | 0 | Palliative (P) | 2017-05-07 | 2017-05-07 | BENDAMUSTINE + RITUXIMAB | N | N | 250032851 | VINORELBINE |
| 250007740 | 250005377 | null | 70 | Curative (C) | 2013-04-12 | 2013-04-15 | GemCarbo Days 1+8 | 02 | N | 250032852 | IPILIMUMAB |
| 250007741 | 250005377 | null | 81.7 | Palliative (P) | null | 2016-05-03 | Trial Unspecified | N | N | 250032852 | CISPLATIN + PACLITAXEL |
| 250007743 | 250005379 | 0 | 62 | Palliative (P) | 2016-08-22 | 2016-09-05 | Pemetrexed | N | N | 250032867 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 250007744 | 250005380 | 1.4 | 71 | Disease modification (D) | 2016-04-14 | 2016-04-14 | Trial Unspecified | 2 | N | 250032872 | TRIAL |